Main menu

NCM 2023 Houston: Building and applying global pathogen surveillance in a post/peri-pandemic world


APHL Global Health leverages next-generation sequencing (NGS), bioinformatics, and genomic epidemiology to enhance public health decision-making in 78 countries. NGS emerged as a crucial component of the COVID-19 pandemic response, with internal and external investments catalyzing advancements in global pathogen genomic capabilities. We emphasize establishing regional capacities in a post/peri-pandemic setting, enabling real-time technical support. A fundamental principle is prioritizing a south-to-south global approach, fostering collaboration among nations with similar challenges. Crucially, we aim to assess the costs of pathogen genomics initiatives, ensuring their long-term sustainability. Exploring diverse use cases demonstrates the broad impact of pathogen genomics on public health outcomes, attracting funding from various entities. While the COVID-19 pandemic brought enduring challenges, it accelerated global pathogen genomics by a decade. APHL seeks to harness this momentum by showcasing the transformative potential of NGS technology, bioinformatics, genomic epidemiology, and data visualization, fostering better health outcomes at individual and population levels

Authors: Noah C. Hull

入门指南

购买 MinION 启动包 Nanopore 商城 测序服务提供商 全球代理商

纳米孔技术

订阅 Nanopore 更新 资源库及发表刊物 什么是 Nanopore 社区

关于 Oxford Nanopore

新闻 公司历程 可持续发展 领导团队 媒体资源和联系方式 投资者 合作者 在 Oxford Nanopore 工作 职位空缺 商业信息 BSI 27001 accreditationBSI 90001 accreditationBSI mark of trust
Chinese flag